Research protocol and recruitment redesign of a study of pregnant women and their infants during the COVID-19 pandemic: Childhood Allergy and the NeOnatal Environment (CANOE)
Open Access
- 1 May 2024
- journal article
- research article
- Published by Elsevier in Journal of Allergy and Clinical Immunology: Global
- Vol. 3 (3) , 100270
Abstract
No abstract availableKeywords
Funding Information
- World Health Organization
- National Institutes of Health (5UH3 OD023282, UG3 OD035517, UG3 OD035509, UG3 OD035518, UG3 OD035521)
- Sanofi Pasteur
- American Thoracic Society
- Pfizer
This publication has 13 references indexed in Scilit:
- Impact of the COVID-19 pandemic on ongoing health research: an ad hoc survey among investigators in GermanyBMJ Open, 2021
- Definition of Clinically Meaningful Within-Patient Changes in POEM and CDLQI in Children 6 to 11 Years of Age with Severe Atopic DermatitisDermatology and Therapy, 2021
- The COVID-19 pandemic and new clinical trial activationsTrials, 2021
- Reports of Forgone Medical Care Among US Adults During the Initial Phase of the COVID-19 PandemicJAMA Network Open, 2021
- Delay or Avoidance of Medical Care Because of COVID-19–Related Concerns — United States, June 2020MMWR. Morbidity and Mortality Weekly Report, 2020
- COVID-19 and readjusting clinical trialsThe Lancet, 2020
- COVID-19 impact on research, lessons learned from COVID-19 research, implications for pediatric researchPediatric Research, 2020
- EASI, (objective) SCORAD and POEM for atopic eczema: responsiveness and minimal clinically important differenceAllergy, 2011
- Patient-Oriented SCORAD (PO-SCORAD): a new self-assessment scale in atopic dermatitis validated in EuropeAllergy, 2011
- Clinical Validation and Guidelines for the SCORAD Index: Consensus Report of the European Task Force on Atopic DermatitisDermatology, 1997